Suppr超能文献

生物验证新型 Western blot 定量过程和产品。

Biological validation of a novel process and product for quantitating western blots.

机构信息

Thermo Fisher Scientific, 5781 Van Allen Way, Carlsbad, CA, 92008-7321, United States.

Thermo Fisher Scientific, 5781 Van Allen Way, Carlsbad, CA, 92008-7321, United States.

出版信息

J Biotechnol. 2021 Jan 20;326:52-60. doi: 10.1016/j.jbiotec.2020.12.012. Epub 2020 Dec 26.

Abstract

Protein normalization of western blots has relied upon housekeeping proteins which exhibit signal saturation and varied cellular expression level variations. These issues can produce spurious results leading to erroneous conclusions. A superior method to protein normalization using housekeeping proteins is Total Protein Normalization, a method now recognized as the gold standard for quantitative westerns. Total Protein Normalization requires that all proteins on a membrane be stained or labeled uniformly, imaged, and then analyzed for total protein. It is important that such a normalization process not interfere with typical immunodetection methods, fits within existing western workflows, and exhibits a linear relationship of signal intensity to protein load under all experimental conditions. Here we report that we developed a new reagent enabling Total Protein Normalization, and we demonstrate its superior protein normalization capabilities through analysis of target proteins in different cell backgrounds. These data illustrate how housekeeping proteins exhibit signal saturation, yield erroneous normalization data, and display sample-to-sample variations averaging 48.2 % overall. Signal intensities obtained using our new method show a linear relationship to protein sample load, thus providing accurate protein normalization with an overall average variation of 7.7 %.

摘要

蛋白质印迹的蛋白归一化一直依赖于看家蛋白,这些蛋白表现出信号饱和和不同的细胞表达水平变化。这些问题可能会产生虚假结果,导致错误的结论。使用看家蛋白进行蛋白质归一化的一种更好的方法是总蛋白归一化,该方法现在被认为是定量蛋白质印迹的金标准。总蛋白归一化要求膜上的所有蛋白均匀染色或标记,成像,然后分析总蛋白。重要的是,这种归一化过程不应干扰典型的免疫检测方法,适应当前的蛋白质印迹工作流程,并且在所有实验条件下,信号强度与蛋白负载之间呈线性关系。在这里,我们报告说,我们开发了一种新的试剂来实现总蛋白归一化,并通过在不同细胞背景下分析靶蛋白来证明其优越的蛋白归一化能力。这些数据说明了看家蛋白如何表现出信号饱和,产生错误的归一化数据,并显示出平均为 48.2%的样本间变化。使用我们的新方法获得的信号强度与蛋白样品负载呈线性关系,因此可以进行准确的蛋白归一化,总体平均变化为 7.7%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验